Original paper
Target therapies plus somatostatin analogs in NETs: a network meta-analysis
Abstract
Although combination therapy is not recommended in patients with gastro–entero–pancreatic (GEP) neuroendocrine tumors (NETs), this strategy is widely used in clinical practice. This network meta-analysis of randomized trials evaluates targeted therapies and somatostatin analogues in GEP-advanced NETs, either alone or in combination, comparing the efficacy of different, single or combined treatment strategies in terms of progression-free survival...
Paper Details
Title
Target therapies plus somatostatin analogs in NETs: a network meta-analysis
Published Date
May 12, 2021
Journal
Volume
28
Issue
7
Pages
467 - 479